Eleison Pharmaceuticals LLC has a total of 13 patent applications. Its first patent ever was published in 2012. It filed its patents most often in Canada, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals are FEDERAL NOE G BJUDZHETNOE UCHREZHDENIE NTS NEVROLOGII ROSSIJSKOJ AKADEMII MED NAUK FGBU NTSN RAMN, UNIV NANJING TRAD CHINESE MED and SANOFI SYNTHELABO OTC S P A.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 2 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Hong Kong | 2 | |
#5 | Japan | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Anthony Forrest H | 11 |
#2 | Thomas Edwin J | 11 |
#3 | Parris Matthew M | 6 |
#4 | Parris Matthew | 5 |
#5 | Zhang Quangtao | 5 |
#6 | Matthew Parris | 2 |
#7 | Forrest H Anthony | 2 |
#8 | Edwin J Thomas | 2 |
#9 | Zhang Guangtao | 1 |
Publication | Filing date | Title |
---|---|---|
CN105025904A | Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin | |
EP2846638A1 | Glufosfamide combination therapies for cancer |